SCHEMBL977234

SCHEMBL977234

CCOC(=O)c1ccc(C(=O)c2ccc(OCc3ccccc3)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 2/20 0.68
SMN1; SMN2 Q16637 3/20 0.64
ALDH1A1 P00352 3/20 0.64
HTT P42858 2/20 0.64
GAA P10253 1/20 0.64
MAPT P10636 1/20 0.64
RAB9A P51151 1/20 0.64
L3MBTL1 Q9Y468 2/20 0.63
MAOB P27338 1/20 0.61
NR4A1 P22736 1/20 0.60
NR4A2 P43354 1/20 0.60
NR4A3 Q92570 1/20 0.60
LMNA P02545 1/20 0.59
PARP10 Q53GL7 1/20 0.57
PPARG P37231 2/20 0.56
NR1H4 Q96RI1 1/20 0.56
RXRA P19793 1/20 0.56
RXRB P28702 1/20 0.56
ADRB2 P07550 1/20 0.56
ADRB1 P08588 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL340618 0.96 MAOB (0.67) SRD5A2SMN1; SMN2ALDH1A1HTTGAA
SCHEMBL11602002 0.90 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1HTTGAAMAPT
SCHEMBL978523 0.89 MAOB (0.58) SRD5A2SMN1; SMN2ALDH1A1HTTGAA
SCHEMBL3232949 0.86 SRD5A2 (0.90) SRD5A2SMN1; SMN2ALDH1A1HTTGAA
SCHEMBL50807 0.85 KMT2A (0.73) SRD5A2SMN1; SMN2ALDH1A1HTTGAA
SCHEMBL402300 0.85 SRD5A2 (0.87) SRD5A2SMN1; SMN2ALDH1A1HTTGAA
SCHEMBL977023 0.84 MAOB (0.53) SRD5A2SMN1; SMN2ALDH1A1MAPTL3MBTL1
SCHEMBL3002718 0.84 MEN1 (0.53) SRD5A2SMN1; SMN2ALDH1A1HTTGAA
SCHEMBL20830918 0.84 KMT2A (0.67) SMN1; SMN2ALDH1A1GAAMAPTRAB9A
SCHEMBL11601531 0.84 MAOB (0.69) SMN1; SMN2ALDH1A1GAAMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110003815-A1 DIPHENYL SUBSTITUTED CYCLOALKANES MERCK & CO., INC. 2011-01-06 US disclosed
US-20110003815-A1 DIPHENYL SUBSTITUTED CYCLOALKANES MERCK & CO., INC. 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003815-A1 DIPHENYL SUBSTITUTED CYCLOALKANES PTGIS, PTGS1, LTC4S SRD5A2 1148/4885SMN1; SMN2 3930/4885ALDH1A1 292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.